Literature DB >> 7226092

Specific immunotherapy of advanced renal carcinoma: evidence for the polyclonality of metastases.

C S McCune, D V Schapira, E C Henshaw.   

Abstract

Autologous, irradiated (10,000 rads) tumor cells mixed with C. parvum were given weekly to 14 patients with metastatic renal carcinoma. The tumor tissue had been cryopreserved with DMSO. No significant toxicity was produced. Four patients underwent objective responses, and a fifth had prolonged stabilization (27+ months). Varying responses occurred simultaneously in different metastatic lesions within the same patient. Responding patients usually had an excellent ambulatory status and received greater than 20 x 10(7) tumor cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7226092     DOI: 10.1002/1097-0142(19810415)47:8<1984::aid-cncr2820470814>3.0.co;2-j

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Renal cell carcinoma treated by vaccines for active specific immunotherapy: correlation of survival with skin testing by autologous tumor cells.

Authors:  C S McCune; R W O'Donnell; D M Marquis; D M Sahasrabudhe
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 2.  Update in cancer chemotherapy: genitourinary tract cancer, Part 1.

Authors:  J C Wright
Journal:  J Natl Med Assoc       Date:  1987-12       Impact factor: 1.798

3.  Clinical responses with active specific intralymphatic immunotherapy for cancer--a phase I-II trial.

Authors:  C L Wiseman; V S Rao; P S Kennedy; C A Presant; J D Smith; R J McKenna
Journal:  West J Med       Date:  1989-09

4.  Clinical studies on cell-mediated immunity in patients with renal cell carcinoma: interleukin-2 and interferon-gamma production of lymphocytes.

Authors:  S Ikemoto; S Wada; M Kamizuru; N Hayahara; T Kishimoto; M Maekawa
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

5.  The selective nature of metastasis.

Authors:  J E Talmadge
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

6.  Tumor vaccines in renal cell carcinoma.

Authors:  Hirotsugu Uemura; Marco A De Velasco
Journal:  World J Urol       Date:  2008-03-12       Impact factor: 4.226

7.  A trial of postoperative adjuvant combination chemo-immunotherapy for stage IV gastric carcinoma.

Authors:  T Akiyoshi; S Arinaga; K Takamuku; T Wada; F Koba; H Tsuji
Journal:  Jpn J Surg       Date:  1988-09

8.  Comparative genomic analysis of primary and synchronous metastatic colorectal cancers.

Authors:  Sun Young Lee; Farhan Haq; Deokhoon Kim; Cui Jun; Hui-Jong Jo; Sung-Min Ahn; Won-Suk Lee
Journal:  PLoS One       Date:  2014-03-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.